Scientific Program

Download program as pdf

Thursday, May 19, 2022

14:00 – 14:05 Welcome Address: Michael Synowitz (Co-Chair), UKSH, Kiel)
14:05 – 15:25 Session I
Chair: Susanne Wolf (Charité, Berlin)
14:05 – 14:45 Plenary Lecture I
Gabriele Bergers (VIB-KU Leuven Center for Cancer Biology, Belgium)
METABOLIC TRAITS OF GLIOMA INVASION
  Oral Presentations I
14:45 – 15:05 Katarzyna Leszczynska (Neurobiology Center, Nencki Institute of Experimental Biology, Warsaw, Poland)

Hypoxia drives repression of multiple pathways through epigenetic reprogramming of glioblastoma

15:05 – 15:25 Agnieszka Chryplewicz (Swiss Institute for Experimental Cancer Research (ISREC), Swiss Federal Institute of TechnologyLausanne, Switzerland)
CO-TARGETING AUTOPHAGY, MACROHAGES AND VASCULATURE IN GLIOMA TUMORS TRIGGERS IMMUNOGENICITY
15:25 – 16:10 Poster Session and Coffee Break
16:10 – 17:40 Session II
Chair: Michela Serresi (MDC, Berlin)
16:10 – 16:50 Plenary Lecture II
Manuel Valiente (CNIO - Centro Nacional de InvestigacionesOncológicas, Madrid, Spain)
EXPLOITING THE TRANSLATIONAL POTENTIAL OF ESTABLISHED AND NEW BRAIN METASTASIS MODELS
  Oral Presentations II
16:55 – 17:10 Lisa Sevenich (Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany)
DISSECTING THE ROLE OF CSF2Rb-STAT5 SIGNALING IN TUMOR-ASSOCIATED INFLAMMATION IN BRAIN METASTASIS
17:10 – 17:30 Philip Schmassmann (Department of Biomedicine, University of Basel, Switzerland)
MICROGLIA-SPECIFIC DISRUPTION OF SIALIC ACID-SIGLEC-9/E INTERACTIONS: A NOVEL IMMUNOTHERAPY AGAINST GLIOBLASTOMA?
17:30 – 18:15 Poster Session and Coffee Break
18:15 – 19:35 Session III
Chair: Charlotte Flüh (UKSH, Kiel)
18:15 – 18:55
 
Plenary Lecture III
Itay Tirosch (Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel)
DISSECTING INTRA-TUMOR AND INTER-TUMOR HETEROGENEITY IN GLIOMA
  Oral Presentations III
18:55 – 19:15 Jasim Kada Benotmane (Neurosurgery, Albert-Ludwigs-University Freiburg, Germany)                               
SPATIALLY RESOLVED T-CELL RECEPTOR SEQUENCING (SPTCR-SEQ) UNCOVERS REGIONAL DIVERSITY OF ANTI-TUMOR IMMUNE RESPONSES
19:15 – 19:35 Björn Brändl (Zentrum für Integrative Psychiatrie -ZIP Kiel, Kiel, Germany)
IntraEpiGliom- Rapid sequencing-based diagnosis of brain tumors
20:00 Reception at the Stadtgut Buch Barn

 

 

Friday, May 20, 2022

9:00 – 9:40 Session IV
Chair: Gaetano Gargiulo (MDC, Berlin)
9:00 – 9:40
 
Plenary Lecture IV
Giulio F. Draetta (Genomic Medicine Department, Unit 1954, The University of Texas MD Anderson Cancer Center, Houston, USA)
A NOVEL POTENTIAL THERAPEUTIC TARGET IN GLIOBLASTOMA
9:40 – 10:20 Poster Session and Coffee Break
10:20 – 11:40 Session V
Chair: Pilar Sanchez (MDC)
10:20 – 11:00 Plenary Lecture V
Marcel Kool (Kitz Hopp Children's Cancer Center, Heidelberg, Germany)
PEDIATRIC BRAIN TUMORS: HOW TO TRANSLATE ALL THE MOLECULAR DATA INTO SUCCESSFUL TREATMENTS FOR PATIENTS?
  Oral Presentations IV
11:00 – 11:20 Ilon Liu (Pediatric Oncology, Dana-Farber Cancer Institute, Boston, USA)
THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION
11:20 – 11:40
 
Catia Neto (School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK)
AN IPSC-DERIVED MULTICELLULAR PLATFORM TO STUDY BRAIN TUMOURS
11:40 – 12:30 Lunch (Cafeteria) and Poster Session
12:30 – 13.50 Session VI
Chair: Christoph Harms (Charité, Berlin)
12:30 – 13:10
 
Plenary Lecture VI
Rainer Glass (NeurochirurgischeForschung am Klinikum der Universität München, Germany)
CONVERTING NFKB INTO A TUMOR-SUPPRESSOR
  Oral Presentations V
13:10 – 13:30 Raphaela Pensch (Department of Medical Biochemistry and Microbiology, Uppsala University, Sweden)
LEVERAGING EVOLUTIONARY CONSTRAINT TO IDENTIFY PUTATIVE NON-CODING DRIVERS IN GLIOBLASTOMA
13:30 – 13:50 Davide Ceresa (Cellular Oncology Unit, IRCCS S.Martino - IST Genova, Genova, Italy
MYC-DRIVEN GAME OF CLONES IN GLIOBLASTOMA PROGRESSION REVEALED BY GENETIC BARCODING
13:50 – 14:30 Poster Session and Coffee Break
14:30 – 16:10 Session VII
Chair: Matthias J. Schmitt (MDC, Berlin)
  Oral Presentations VI
14:30 – 14:50 Kieron White (Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland)
TRANSCRIPTOMIC ANALYSIS REVEALS NOVEL TUMOUR MICROENVIRONMENT SUBTYPES IN ISOCITRATE DEHYDROGENASE WILDTYPE GLIOBLASTOMA
14:50 – 15:10 Aviel Iluz (Department of Neurology, Hadassah Medical Center, Hebrew University of Jerusalem, Israel)
THE USE OF METHYLATION FINGERPRINTS TO INVESTIGATE THE CELL-OF-ORIGIN OF GLIOMAS
15:10 – 15:30 Valentina Pieri (IRCCS San Raffaele Scientific Institute, Milan, Italy)
PLASMA CFDNA LIQUID BIOPSY IN THE FOLLOW-UP OF HIGH-GRADE GLIOMAS
15:30 – 16:10 Plenary Lecture VII
Antonio Iavarone (Institute for Cancer Genetics, Columbia University Medical Center, New York, USA)
MECHANISMS OF ONCOGENESIS AND PRECISION MEDICINE OF GLIOBLASTOMA
16:10 – 16:15 Awarding of Poster Prizes
16:15 Departure
   
   
   

Our partners

Commercial partners:
 
 
     
Partner Organisations:

European Association of NeuroOncology

British Neuro-Oncology Society